Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.[E12]

From the notice

Titre : Demande de propositions (DP) pour des tests pharmacologiques sur de nouveaux stimulants et cannabinoïdes synthétiques. Amended Request For Proposal (RFP) for Pharmacological testing of stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of two categories of emerging drugs: synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the OLRA to make more informed regulatory science decisions. For both streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Stimulants, and Synthetic Cannabinoids in two (2) separate streams to Health Canada. Stream 2 – In vitro pharmacological testing of…[E5]

• ConditionDelivery regions: National Capital Region (NCR).[E6]
• ConditionTrade agreements that apply: North American Free Trade Agreement (NAFTA); Canada-Korea Free Trade Agreement (CKFTA).[E7]
• The notice data states no restriction on who may bid. Exclusion grounds and selection criteria in the tender documents still apply.

• UnknownThe notice does not state a value.
• UnknownWe read the published notice, not the full tender documents.

1. First seen · 28 Oct 2026, 13:27 UTC

   The source published a call for competition with a future deadline.

   Source document cb-912-87371785@000@Open

Every fact on this page comes from the published notice. Each entry shows the document and the field it was read from.

1. E1

   The buyer is Department of Health (HC).

   Document cb-912-87371785@000@Open, field /contractingEntityName-nomEntitContractante-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

2. E2

   The notice is classified under UNSPSC 51000000 (Drugs and Pharmaceutical Products).

   Document cb-912-87371785@000@Open, field /unspsc, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

3. E3

   CanadaBuys publishes Government of Canada tenders.

   “CA”

   Document cb-912-87371785@000@Open, field /contractingEntityName-nomEntitContractante-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

4. E4

   Bids close at (Eastern Time assumed: the open data states no zone) 9 Nov 2026, 17:00 GMT-5.

   “2026-11-09T17:00:00”

   Document cb-912-87371785@000@Open, field /tenderClosingDate-appelOffresDateCloture, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

5. E5

   The buyer describes the requirement in the notice.

   “Amended Request For Proposal (RFP) for Pharmacological testing of stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs incr…”

   Document cb-912-87371785@000@Open, field /tenderDescription-descriptionAppelOffres-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

6. E6

   Delivery regions: National Capital Region (NCR).

   Document cb-912-87371785@000@Open, field /regionsOfDelivery-regionsLivraison-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

7. E7

   Trade agreements that apply: North American Free Trade Agreement (NAFTA); Canada-Korea Free Trade Agreement (CKFTA).

   Document cb-912-87371785@000@Open, field /tradeAgreements-accordsCommerciaux-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

8. E8

   This is a Request for Proposal on CanadaBuys.

   Document cb-912-87371785@000@Open, field /noticeType-avisType-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

9. E9

   The procurement method is Competitive - Open bidding.

   Document cb-912-87371785@000@Open, field /procurementMethod-methodeApprovisionnement-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

10. E10

    The notice was published on 27 Oct 2026.

    “2026-10-27”

    Document cb-912-87371785@000@Open, field /publicationDate-datePublication, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

11. E11

    CanadaBuys gives the status as Open.

    Document cb-912-87371785@000@Open, field /tenderStatus-appelOffresStatut-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

12. E12

    The notice is titled "Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.".

    Document cb-912-87371785@000@Open, field /title-titre-eng, read 28 Oct 2026, 13:27 UTC · source ↗ (opens in a new tab)

Contains information licensed under the Open Government Licence – Canada (CanadaBuys). Data licence: Open Government Licence – Canada 2.0 ↗ (opens in a new tab). Personal contact details in notices are not stored or shown.